IntroductionDrug delivery can play an important role at all stages of a drug's lifecycle and has become an ever present feature in the business model of the leading pharmaceutical companies. Using the PharmaVitae Explorer database, the report provides an in depth sales analysis of the specific routes of administration driving the pharmaceutical market out to 2014ScopeAssess how drug delivery has become an ever present feature in the business model of the leading pharmaceutical companiesProvides an insight into the prominent technology types in the expansive drug delivery segmentBenchmarks the sales performance of the leading prescription pharmaceutical companies in terms of drug deliveryHighlightsThe oral and injectable segments are the dominant routes of administration in the prescription pharmaceutical market, accounting for more than 80% of combined sales in 2008.Injectables will see the biggest increase in annual sales at $49 billion over 200814. In contrast, oral drugs will collectively decline by $10.9 billion over the same period.Slow-growth therapy areas are generally entrenched in oral medications. This dynamic is mirrored by the fast-growth therapy areas, where novel injectable drugs will primarily drive growth.Reasons to PurchaseAssess the ways in which drug delivery technology to add value to pharmaceutical productsDetermine current R&D trends in the drug delivery segmentExamine the long-term sales performance of each delivery type across the leading prescription pharmaceutical players

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Benchmarking the Pharmaceutical Market by Drug Delivery to 2014
Published on December 2009
Report Summary
Introduction
Drug delivery can play an important role at all stages of a drug's lifecycle and has become an ever present feature in the business
model of the leading pharmaceutical companies. Using the PharmaVitae Explorer database, the report provides an in depth sales
analysis of the specific routes of administration driving the pharmaceutical market out to 2014
Scope
Assess how drug delivery has become an ever present feature in the business model of the leading pharmaceutical
companiesProvides an insight into the prominent technology types in the expansive drug delivery segmentBenchmarks the sales
performance of the leading prescription pharmaceutical companies in terms of drug delivery
Highlights
The oral and injectable segments are the dominant routes of administration in the prescription pharmaceutical market, accounting for
more than 80% of combined sales in 2008.
Injectables will see the biggest increase in annual sales at $49 billion over 200814. In contrast, oral drugs will collectively decline by
$10.9 billion over the same period.
Slow-growth therapy areas are generally entrenched in oral medications. This dynamic is mirrored by the fast-growth therapy areas,
where novel injectable drugs will primarily drive growth.
Reasons to Purchase
Assess the ways in which drug delivery technology to add value to pharmaceutical productsDetermine current R&D trends in the drug
delivery segmentExamine the long-term sales performance of each delivery type across the leading prescription pharmaceutical
players
Table of Content
TABLE OF CONTENTS
ABOUT DATAMONITOR HEALTHCARE 2
About the PharmaVitae team 2
Chapter 1 About this report 3
PharmaVitae Explorer database 3
Chapter structure 4
Data sourcing 4
Benchmarking the Pharmaceutical Market by Drug Delivery to 2014 Page 1/5

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Chapter 2 Executive summary 5
Key findings 5
Drug delivery overview 6
Prescription pharmaceutical market by delivery mechanism, 2002'14 12
Chapter 3 Overview of drug delivery market 27
Key findings 27
Introduction to drug delivery 28
Chapter 4 Segmentation of the drug delivery market 34
Key findings 34
Segmentation of the drug delivery market 35
Segmentation by mode of delivery 37
Segmentation by technology type 45
Merging technology with commercial opportunity 48
Chapter 5 Sales analysis of the pharmaceutical market by drug delivery 50
Key findings 50
A delivery-focused sales analysis of the leading prescription pharmaceutical companies 51
Prescription pharmaceutical market by delivery mechanism 53
Drug delivery analysis of the leading pharmaceutical players by company 67
Drug delivery analysis of the leading pharmaceutical players by company 74
Chapter 6 Appendix 80
References 80
Abbreviations 80
Exchange rates 81
About Datamonitor 82
Datamonitor consulting 82
Disclaimer 84
TABLE OF TABLES
Table 1: Classification system employed to dissect the delivery technology space 35
Table 2: The principal modes of delivery in the pharmaceutical industry 37
Table 3: List of companies covered by PharmaVitae 51
Table 4: Exchange rates, 2009 81
TABLE OF FIGURES
Figure 1: The PharmaVitae Explorer 3
Figure 2: Drug delivery systems can improve the therapeutic and commercial performance of a pharmaceutical product 6
Figure 3: A selection of pharmaceutical players operating within the drug delivery space 8
Figure 4: Segmentation of the drug delivery space by technology type 9
Figure 5: Drug delivery system by mode of administration 10
Figure 6: Technology count vs global pharma market share by delivery mechanism 11
Figure 7: Prescription pharmaceutical market by delivery mechanism, sales ($m), 2002'14 12
Figure 8: Compound annual growth rates by delivery mechanism (%), 2008'14 13
Figure 9: Absolute sales growth by delivery mechanism between 2008 and 2014 ($m) 14
Figure 10: Therapy area forecasts segmented by delivery mechanism 15
Figure 11: Product lifecycle stage forecasts segmented by delivery mechanism 16
Figure 12: Technology type forecasts segmented by delivery mechanism 17
Figure 13: Top 20 companies ranked by 2008 oral sales 18
Figure 14: Top 20 companies ranked by 2008 injectable sales 19
Figure 15: Top 20 oral products ranked by 2014 sales 20
Benchmarking the Pharmaceutical Market by Drug Delivery to 2014 Page 2/5

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Figure 16: Top 20 injectable products ranked by 2014 sales 21
Figure 17: Drug delivery systems can improve the therapeutic and commercial performance of a pharmaceutical 29
Figure 18: Johnson & Johnson Risperdal franchise sales ($m), 2002'08 31
Figure 19: A selection of pharmaceutical players operating within the drug delivery space 36
Figure 20: Segmentation of drug delivery space by modality and technology 38
Figure 21: Segmentation of the drug delivery space by technology type 45
Figure 22: Drug delivery system by mode of administration 47
Figure 23: Technology count vs global pharma market share by delivery mechanism 48
Figure 24: Global pharmaceutical market by delivery mechanism 49
Figure 25: Prescription pharmaceutical market by delivery mechanism, sales ($m), 2002'14 53
Figure 26: Compound annual growth rates by delivery mechanism, 2008'14 54
Figure 27: Absolute sales growth by delivery mechanism between 2008 and 2014 ($m) 55
Figure 28: Long-term sales analysis across the delivery space 56
Figure 29: Therapy area forecasts segmented by delivery mechanism 57
Figure 30: Territory-specific forecasts segmented by delivery mechanism 58
Figure 31: Product lifecycle stage forecasts segmented by delivery mechanism 59
Figure 32: Technology type forecasts segmented by delivery mechanism 60
Figure 33: Age of drug forecasts segmented by delivery mechanism 61
Figure 34: Prescription drug sales of Big Pharma peer set by delivery mechanism 62
Figure 35: Prescription drug sales of Biotech peer set by delivery mechanism 63
Figure 36: Prescription drug sales of Generics peer set by delivery mechanism 64
Figure 37: Prescription drug sales of Japan peer set by delivery mechanism 65
Figure 38: Prescription drug sales of Mid Pharma peer set by delivery mechanism 66
Figure 39: Top 20 companies ranked by 2008 oral sales 67
Figure 40: Top 20 companies ranked by 2014 oral sales 68
Figure 41: Oral sales dependency versus long-term growth of the top 20 oral drug companies 69
Figure 42: Top 20 companies ranked by 2008 injectable sales 70
Figure 43: Top 20 companies ranked by 2014 injectable sales 71
Figure 44: Injectable sales dependency versus long-term growth of the top 20 injectables drug companies 72
Figure 45: Injectable sales dependency versus long-term growth of the top 20 injectables drug companies, biologic focus 2014 (%) 73
Figure 46: Top 20 oral products ranked by 2008 sales 74
Figure 47: Top 20 oral products ranked by 2014 sales 75
Figure 48: Oral growth drivers/resistors, 2008'14 76
Figure 49: Top 20 injectable products ranked by 2008 sales 77
Figure 50: Top 20 injectable products ranked by 2014 sales 78
Figure 51: Injectable growth drivers/resistors, 2008'14 79
Benchmarking the Pharmaceutical Market by Drug Delivery to 2014 Page 3/5

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Benchmarking the Pharmaceutical Market by Drug Delivery to 2014
Product Formats
Please select the product formats and the quantity you require.
Digital Copy--USD 7 600.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Benchmarking the Pharmaceutical Market by Drug Delivery to 2014 Page 4/5

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Benchmarking the Pharmaceutical Market by Drug Delivery to 2014 Page 5/5